{"id":"W1522676959","doi":"10.1111/bcp.12662","title":"Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia","year":2015,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"F. Hoffmann-La Roche","keywords":"Rituximab; Medicine; Fludarabine; Cyclophosphamide; Pharmacokinetics; Internal medicine; Urology; Pharmacology; Gastroenterology; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008173457,0.000348299,0.000782982,0.000167026,0.0001319768,0.0006538707,0.0003424437,0.000502244,0.00139665],"category_scores_gemma":[0.001462694,0.0002214989,0.0003930119,0.0002538762,0.0003698766,0.0003461035,0.0001661389,0.001111014,0.0003838706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007003343,"about_ca_system_score_gemma":0.0006365387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000751365,"about_ca_topic_score_gemma":0.001234988,"domain_scores_codex":[0.9996033,0.0001991857,0.00002183658,0.00006172523,0.00007231415,0.00004167745],"domain_scores_gemma":[0.9994472,0.0001555922,0.0002075214,0.00003632885,0.00002571729,0.0001276631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2829669,0.01000736,0.06819829,0.000861969,0.001407358,0.0005189672,0.0004507225,0.007638319,0.1788313,0.000191896,0.003041943,0.4458848],"study_design_scores_gemma":[0.1094193,0.5708835,0.2555217,0.0001412429,0.001555569,0.003309204,0.0002229997,0.009774766,0.03940693,0.0002716619,0.00939314,0.00009996266],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969055,0.001964,0.0002977217,0.00009389625,0.00001467155,0.00008354674,0.00008858816,0.00004052729,0.0005114858],"genre_scores_gemma":[0.9987374,0.0003793037,0.000330355,0.00009443372,0.00002550315,0.00004570036,0.0001559719,0.000007100667,0.0002242041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00139665,"threshold_uncertainty_score":0.005081356,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03402879915857482,"score_gpt":0.3734540108024317,"score_spread":0.3394252116438569,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}